Leng, Yinping
Kan, Ao
Wang, Xiwen
Li, Xiaofen
Xiao, Xuan
Wang, Yu
Liu, Lan
Gong, Lianggeng
Article History
Received: 14 August 2023
Accepted: 21 February 2024
First Online: 6 March 2024
Declarations
:
: The studies involving human participants were reviewed and approved by the Institutional Review Board of the Second Affiliated Hospital of Nanchang University, Jiangxi Cancer Hospital, and Jiangxi Provincial People’s Hospital. Since data were evaluated retrospectively, pseudonymously and were solely obtained for treatment purposes, a requirement of informed consent was waived by the Institutional Review Board of the three centers.
: Not applicable.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Yu Wang reports a relationship with Clinical and Technical Support, Philips Healthcare, Shanghai, China that includes: employment. Other remaining authors has no conflict of interest to disclose.